392
Participants
Start Date
September 1, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
July 31, 2027
Dolutegravir Pill
Dose will be based on weight; brand names will be as supplied through the respective national programs
Darunavir+Ritonavir
Dose will be based on weight
RECRUITING
Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu
NOT_YET_RECRUITING
Bomu Hospital, Mombasa
NOT_YET_RECRUITING
Butha-Buthe District Hospital, Butha-Buthe
NOT_YET_RECRUITING
Mokhotlong District Hospital, Mokhotlong
NOT_YET_RECRUITING
CS Ponta Gea, Beira
NOT_YET_RECRUITING
CS Machava II, Maputo
NOT_YET_RECRUITING
CS Ndlavela, Maputo
NOT_YET_RECRUITING
MUHAS Clinical Trial Unit, Dar es Salaam
RECRUITING
Kenyatta National Hospital, Nairobi
Instituto Nacional de Saúde, Mozambique
OTHER_GOV
Muhimbili University of Health and Allied Sciences
OTHER
SolidarMed
OTHER
London School of Hygiene and Tropical Medicine
OTHER
University of Nairobi
OTHER